Education
About Us
Working with TipRanks
Follow Us
M1 Kliniken AG (DE:M12)
XETRA:M12
M12 Stock Chart & Stats
€18.16
-€0.10(-0.64%)
At close: 4:00 PM EST
€18.16
-€0.10(-0.64%)
Day’s Range― - ―
52-Week Range€12.78 - €19.76
Previous CloseN/A
Volume462.00
Average Volume (3M)13.86K
Market Cap
€351.15M
Enterprise ValueN/A
Total Cash (Recent Filing)€45.67M
Total Debt (Recent Filing)€21.82M
Price to Earnings (P/E)18.9
Beta0.21
Next Earnings
Apr 16, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.8%
Share Statistics
EPS (TTM)N/A
Shares Outstanding19,643,402
10 Day Avg. Volume17,849
30 Day Avg. Volume13,861
Financial Highlights & Ratios
PEG Ratio0.32
Price to Book (P/B)2.90
Price to Sales (P/S)0.91
P/FCF Ratio10.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.84
Revenue Forecast (FY)€305.82M
M12 FAQ
What was M1 Kliniken AG’s price range in the past 12 months?
M1 Kliniken AG lowest stock price was €12.78 and its highest was €19.76 in the past 12 months.
What is M1 Kliniken AG’s market cap?
M1 Kliniken AG’s market cap is €351.15M.
When is M1 Kliniken AG’s upcoming earnings report date?
M1 Kliniken AG’s upcoming earnings report date is Apr 16, 2026 which is in 92 days.
How were M1 Kliniken AG’s earnings last quarter?
Currently, no data Available
Is M1 Kliniken AG overvalued?
According to Wall Street analysts M1 Kliniken AG’s price is currently Overvalued.
Does M1 Kliniken AG pay dividends?
M1 Kliniken AG pays a Annually dividend of €0.5 which represents an annual dividend yield of 2.8%. See more information on M1 Kliniken AG dividends here
What is M1 Kliniken AG’s EPS estimate?
M1 Kliniken AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does M1 Kliniken AG have?
M1 Kliniken AG has 19,643,402 shares outstanding.
What happened to M1 Kliniken AG’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of M1 Kliniken AG?
Currently, no hedge funds are holding shares in DE:M12
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
M1 Kliniken AG Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
1.23%
12-Months-Change
Fundamentals
Return on Equity
15.61%
Trailing 12-Months
Asset Growth
0.27%
Trailing 12-Months
Company Description
M1 Kliniken AG
M1 Kliniken AG, together with its subsidiaries, operates medical centers for aesthetic and plastic surgery in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, and Australia. The company operates in two segments, Beauty and Trade. It develops and markets pharmaceutical, medical, and medical technology products for aesthetic medicine and cosmetic dermatology, as well as trades in pharmaceutical, biosimilars, and other medical products and devices in the areas of oncology, HIV, rheumatism, neurology, cardiovascular diseases, and narcotics. The company also engages in the acquisition, management, and sale of real estate, primarily in the health care sector. It offers its products to doctors, pharmacies, and wholesalers under the M1 Select brand. The company operates a network of outpatient specialist centers; and a specialized surgical clinic center, as well as 46 specialist centers under the M1 Med Beauty brand. M1 Kliniken AG was founded in 2007 and is based in Berlin, Germany. M1 Kliniken AG operates as a subsidiary of MPH Health Care AG.
Technical Analysis
MEDICLIN
―
MATERNUS-Kliniken AG
―
Limes Schlosskliniken AG
―
HAEMATO AG
―
MPH Health Care AG
―